| Linda Chang et al.: |
Additive
effects of HIV and chronic methamphetamine use on brain
metabolite abnormalities |
| |
Antiretroviral
treatment alters relationship between MCP-1 and
neurometabolites in HIV patients |
|
Combined
and independent effects of chronic marijuana use and HIV on
brain metabolites |
|
Increased
frontal white matter diffusion is associated with glial
metabolites and psycholotor slowing in HIV |
|
Increased
glial metabolites predict increased working memory network
activation in HIV brain injury |
|
| Gilberto Gonzalez et al.: |
Magnetic
resonance spectroscopy reveals that activated monocytes
contribute to neuronal injury in SIV neuroAIDS |
|
Quantitative
neuropathologic correlates of changes in ratio of
N-acetylaspartate to creatine in Macaque brain |
|
| Glen Hanson et al.: |
The
methamphetamine experience: A NIDA partnership |
|
| Jau-Shyong Hong et al.: |
Microglia
and inflammation-mediated neurodegeneration: Multiple
triggers with a common mechanism |
|
Morphinan
neuroprotection: New insight into the therapy of
neurodegeneration |
|
| Kurt Hauser et al.: |
The
impact of Opiate-HIV-1 interactions on neurotoxic
signaling |
|
HIV-Tat
and opiate-induced changes in astrocytes promote chemotaxis of
microglia through the expression of MCP-1 and alternative
chemokines |
|
| James P. 0'Callaghan et al.: |
Deficiency
of TNF receptors suppresses microglial activation and alters
susceptibility of brain regions to MPTP-induced
neurotoxicity |
|
| Yuri Persidsky et. al: |
Inhibition
of indoleamine 2,3-dioxygenase (IDO) enhances elimination of
virus-infected macrophages in an animal model of HIV-1
encephalitis |
|
Rho-mediated
regulation of tight junctions during monocyte migration across
blood-brain barrier in HIV-1 encephalitis
(HIVE) |
|
